Microorganisms in Recent Drug Discovery

Environmental microbes are a significant source of drug discovery, and several microbial products (anti-tumor products, immunosuppressant, antibiotics and others) are routinely used for human therapy. Most of these products were obtained from cultivable environmental microbes, and this means that the vast majority of microbes were not targeted for drug discovery. With the advent of new and emerging technologies, we are poised to harvest novel drugs from the so-called 'uncultivable' microbes. In this article, we propose how a multidisciplinary approach combining different technologies can expedite and revolutionize drug discovery from uncultivable microbes and examine the current limitations of technologies and strategies to overcome such limitations that might further expand the promise of drugs from environmental microbes.

  • Novel species discovery
  • Novel species discovery
  • Genetically modified organisms

Related Conference of Microorganisms in Recent Drug Discovery

July 03-04, 2023

15th International Virology Summit

London, UK
July 10-11, 2023

8th International Conference on Bacteriology

Valencia, Spain
July 26-27, 2023

29th Global Summit on Bioinformatics

Montreal, Canada
August 17-18, 2023

4th International Conference on Molecular Microbiology

Dublin, Ireland
October 25-26, 2023

10th World Congress on Microbiology & Infectious Diseases

Zurich, Switzerland
November 13-14, 2023

11th Global Medical Microbiology Summit & Expo

Edinburgh, Scotland
November 15-16, 2023

11th World Congress and Expo on Applied Microbiology

Barcelona, Spain
November 20-21, 2023

6th World Congress on Virology and Diseases Control

London, UK
November 27-28, 2023

6th Global Summit on Microbiome

Budapest, Hungary
December 04-05, 2023

23rd Global Conference on Gerontology

Venice, Italy
December 15-16, 2023

27th World Congress on Biotechnology

Amsterdam, Netherlands

Microorganisms in Recent Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in